Latest News for: serina

Edit

Statement of Changes in Beneficial Ownership (Form 4) (Serina Therapeutics Inc)

Public Technologies 23 Dec 2025
Serina Therapeutics, Inc ... The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the ... Serina Therapeutics Inc.
Edit

Enable Injections Announces Regulatory Approval in Saudi Arabia for the EMPAVELI® Injector based on enFuse® Technology (Serina Therapeutics Inc)

Public Technologies 18 Dec 2025
). CINCINNATI, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc ... "Gaining SFDA authorization is a meaningful step for Enable," said Michael D. Hooven, Chairman and CEO of Enable Injections ... Media Contact. ... Source ... Serina Therapeutics Inc.
Edit

Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry

Nasdaq Globe Newswire 11 Dec 2025
HUNTSVILLE, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American ... .
Edit

Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program

Nasdaq Globe Newswire 10 Dec 2025
– Company addresses FDA requests regarding formulation excipient. – Global site start-up activities continue, with first-patient-in for registrational Phase 1b study targeted for Q1 2026, subject to FDA feedback ... .
Edit

Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program (Form 8-K) (Serina Therapeutics Inc)

Public Technologies 10 Dec 2025
) Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program ... HUNTSVILLE, Dec 10, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ("Serina" or the "Company") (NYSE American.
Edit

Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

Nasdaq Globe Newswire 13 Nov 2025
13, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American ... .
Edit

Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights (Form 8-K) (Serina Therapeutics Inc)

Public Technologies 13 Nov 2025
) Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights. HUNTSVILLE, November 13, 2025 (GLOBE NEWSWIRE) - Serina Therapeutics, Inc. ("Serina" or the "Company") (NYSE American.
Edit

Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q) (Serina Therapeutics Inc)

Public Technologies 13 Nov 2025
On March 26, 2024, we completed the Merger, pursuant to which Merger Sub merged with and into Legacy Serina, with Legacy Serina surviving as our wholly owned subsidiary ... Serina Therapeutics Inc.
Edit

Proxy Results (Form 8-K) (Serina Therapeutics Inc)

Public Technologies 12 Nov 2025
) Item 5.07 Submission of Matters to a Vote of Security Holders. The Board of Directors of Serina Therapeutics, Inc ... A quorum was present at the meeting ... Proposal 1. Election of Two Directors ... Nominees. For. Withheld ... Steve Ledger ... - ... Serina Therapeutics Inc.
Edit

Serina Therapeutics Provides Regulatory Update on SER-252 Program (Form 8-K) (Serina Therapeutics Inc)

Public Technologies 03 Nov 2025
) Serina Therapeutics Provides Regulatory Update on SER-252 Program ... 3, 2025 -- Serina Therapeutics, Inc. ("Serina") (NYSE American ... Serina intends to work expeditiously with the FDA to address the requests ... About Serina Therapeutics.
Edit

Serina Therapeutics Provides Regulatory Update on SER-252 Program

Nasdaq Globe Newswire 03 Nov 2025
- FDA requests additional information on a formulation component - ... .
Edit

Revised Proxy Soliciting Materials (Form DEFR14A) (Serina Therapeutics Inc)

Public Technologies 27 Oct 2025
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. WASHINGTON, D.C. 20549. SCHEDULE 14A. (Rule 14a-101) ... 1) ... Serina Therapeutics, Inc ... 1 (this "Amendment") amends the definitive proxy statement of Serina Therapeutics, Inc ... Serina Therapeutics Inc.
Edit

Notice of Proposed Sale of Securities (Form 144) (Serina Therapeutics Inc)

Public Technologies 14 Oct 2025
). The text version of this document is not available ... Serina Therapeutics Inc.
Edit

Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors

Nasdaq Globe Newswire 08 Oct 2025
08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American ... .
Edit

Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease (Form 8-K) (Serina Therapeutics Inc)

Public Technologies 06 Oct 2025
) Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson's Disease ... HUNTSVILLE, AL, October 06, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ("Serina") (NYSE American.

Article Search

tools
×
×
×
×